This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| COVID-19 | 400 |
| NAD | 177 |
| NR | 165 |
| C | 154 |
| Table | 138 |
| Food | 136 |
| Health | 129 |
| D | 125 |
| Se | 122 |
| MedDiet | 121 |
| DHA | 115 |
| mg | 113 |
| EPA | 110 |
| SARS | 105 |
| PRE | 100 |
| AMPK | 93 |
| Cancer | 93 |
| D3 | 91 |
| TNF | 83 |
| Nutrition | 79 |
| CCK | 77 |
| IFN | 75 |
| China | 75 |
| meta | 67 |
| BMI | 67 |
| CI | 66 |
| United | 65 |
| L. | 65 |
| CoV-2 | 64 |
| L | 64 |
| T | 64 |
| IU | 63 |
| USA | 62 |
| α | 60 |
| States | 59 |
| RNA | 59 |
| CACFP | 59 |
| RSV | 58 |
| Disease | 58 |
| κB | 57 |
| IgG | 57 |
| IgA | 54 |
| March | 54 |
| PAH | 54 |
| US | 54 |
| VITD | 52 |
| IL-6 | 52 |
| Review | 51 |
| Study | 50 |
| A | 50 |
| Program | 48 |
| Human | 48 |
| Curcumin | 48 |
| Coronavirus | 45 |
| Diet | 43 |
| Care | 43 |
| Association | 42 |
| Alzheimer | 42 |
| National | 42 |
| Prevention | 42 |
| PUFA | 41 |
| osteosarcopenia | 41 |
| sha | 40 |
| NAD+ | 40 |
| DOI | 40 |
| IL-10 | 39 |
| Figure | 38 |
| February | 38 |
| NF | 37 |
| Selenium | 36 |
| HDL | 36 |
| B | 36 |
| LPS | 35 |
| January | 35 |
| µmol | 35 |
| Mediterranean | 35 |
| Spain | 35 |
| SELENOP | 34 |
| European | 33 |
| Research | 32 |
| CRP | 32 |
| Analysis | 32 |
| Trial | 31 |
| Australia | 30 |
| Clinical | 30 |
| Germany | 30 |
| LL-37 | 30 |
| Survey | 30 |
| ± | 30 |
| MD | 30 |
| • | 29 |
| Nicotinamide | 29 |
| NAM | 29 |
| Effect | 29 |
| CVD | 29 |
| California | 28 |
| HCV | 27 |
| Adult | 27 |
| Europe | 27 |
| FcRn | 27 |
| KJ | 27 |
| ICU | 27 |
| Security | 27 |
| University | 27 |
| β | 27 |
| World | 26 |
| UK | 26 |
| Sarcopenia | 26 |
| GG | 26 |
| BF | 26 |
| April | 26 |
| Adults | 26 |
| Americans | 25 |
| Meta | 25 |
| B. | 25 |
| U.S. | 25 |
| Treatment | 25 |
| kg | 25 |
| PBMC | 24 |
| Organization | 24 |
| New | 24 |
| Italy | 24 |
| II | 24 |
| HIV | 24 |
| Fc | 24 |
| C. | 24 |
| ARDS | 24 |
| Dietary | 23 |
| Diabetes | 23 |
| Cu | 23 |
| Global | 23 |
| Supplementary | 23 |
| Influenza | 23 |
| Poland | 22 |
| IgM | 22 |
| Household | 22 |
| E. | 22 |
| Institute | 21 |
| Group | 21 |
| Immune | 21 |
| Insecurity | 21 |
| MUFA | 21 |
| LDL | 21 |
| NMN | 21 |
| North | 21 |
| CoV | 20 |
| < | 20 |
| Assistance | 20 |
| TE | 20 |
| DM | 20 |
| γ | 20 |
| IL-12 | 20 |
| selenoprotein | 19 |
| rhamnosus | 19 |
| Systematic | 19 |
| Survivors | 19 |
| Supplemental | 19 |
| South | 19 |
| Randomized | 19 |
| Development | 19 |
| CC | 19 |
| Agriculture | 19 |
| G | 18 |
| Activity | 18 |
| Evaluation | 18 |
| vivo | 18 |
| Lactobacillus | 18 |
| PD | 18 |
| Public | 18 |
| J | 17 |
| American | 17 |
| CD38 | 17 |
| Control | 17 |
| Controlled | 17 |
| Diseases | 17 |
| I | 17 |
| S1 | 17 |
| Medical | 17 |
| PTH | 17 |
| RTI | 17 |
| mL | 17 |
| VDR | 17 |
| nan | 17 |
| Model | 16 |
| AICR | 16 |
| ECE | 16 |
| F&V | 16 |
| GSH | 16 |
| HC | 16 |
| International | 16 |
| Obesity | 16 |
| Risk | 16 |
| SRP | 16 |
| Society | 16 |
| Supplementation | 16 |
| Vermont | 16 |
| mRNA | 16 |
| MEDAS | 15 |
| Assessment | 15 |
| Child | 15 |
| Committee | 15 |
| Department | 15 |
| Escherichia | 15 |
| Finland | 15 |
| IL-17 | 15 |
| Social | 15 |
| MNA | 15 |
| Republic | 15 |
| State | 15 |
| USDA | 15 |
| Wuhan | 15 |
| apigenin | 15 |
| nmol | 15 |
| NK | 15 |
| DC | 14 |
| IDL | 14 |
| HIV-1 | 14 |
| France | 14 |
| FFAs | 14 |
| Education | 14 |
| BOP | 14 |
| Chronic | 14 |
| CA | 14 |
| Broussonetia | 14 |
| Asia | 14 |
| Intake | 14 |
| Infections | 14 |
| Guidelines | 14 |
| K | 14 |
| Report | 14 |
| Mechanisms | 14 |
| URTI | 14 |
| TLR | 14 |
| Selenoprotein | 14 |
| SFA | 14 |
| TLR3 | 14 |
| Protein | 14 |
| P | 14 |
| Nutritional | 14 |
| monocyte | 14 |
| Medicine | 14 |
| HDDS | 13 |
| Attribution | 13 |
| CD4 | 13 |
| CFR | 13 |
| CXCL10 | 13 |
| Center | 13 |
| Commons | 13 |
| Creative | 13 |
| DCs | 13 |
| EC | 13 |
| Efficacy | 13 |
| III | 13 |
| San | 13 |
| Zn | 13 |
| VLDL | 13 |
| Spanish | 13 |
| Serum | 13 |
| Therapy | 13 |
| ROS | 13 |
| Patients | 13 |
| Low | 13 |
| Immunoglobulins | 13 |
| Gut | 12 |
| Life | 12 |
| LTA | 12 |
| Impact | 12 |
| IL-8 | 12 |
| IC | 12 |
| HFD | 12 |
| Burden | 12 |
| Frailty | 12 |
| Exercise | 12 |
| Cronbach | 12 |
| CIDEA | 12 |
| Malta | 12 |
| Adherence | 12 |
| Lithuania | 12 |
| CalFresh | 12 |
| Ministry | 12 |
| Riboside | 12 |
| NHANES | 12 |
| papyrifera | 12 |
| Virus | 12 |
| Toll | 12 |
| quercetin | 12 |
| Studies | 12 |
| TPRE | 12 |
| Respiratory | 12 |
| RCTs | 12 |
| Protection | 12 |
| Physical | 12 |
| Periodontitis | 12 |
| Novel | 12 |
| Effects | 11 |
| IL-4 | 11 |
| Hubei | 11 |
| Hg | 11 |
| H1N1 | 11 |
| Flavonoids | 11 |
| ACC | 11 |
| ESPEN | 11 |
| Community | 11 |
| Cardiovascular | 11 |
| Canada | 11 |
| CP | 11 |
| CD8 | 11 |
| June | 11 |
| Inc. | 11 |
| Healthy | 11 |
| Kg | 11 |
| Quercetin | 11 |
| Los | 11 |
| kazinol | 11 |
| Viral | 11 |
| SSc | 11 |
| SNAP | 11 |
| SIRT1 | 11 |
| West | 11 |
| Poly | 11 |
| NAAD | 11 |
| PCR | 11 |
| Outcomes | 11 |
| OO | 11 |
| Non | 11 |
| PE | 11 |
| Head | 10 |
| Helsinki | 10 |
| IL-1 | 10 |
| IL-2 | 10 |
| NAMPT | 10 |
| MAPK | 10 |
| Income | 10 |
| India | 10 |
| MHC | 10 |
| Mann | 10 |
| GDM | 10 |
| HF | 10 |
| ApoE | 10 |
| Examination | 10 |
| EU-28 | 10 |
| Depression | 10 |
| Chinese | 10 |
| Chi | 10 |
| COPD | 10 |
| CAL | 10 |
| Antiviral | 10 |
| Angeles | 10 |
| Africa | 10 |
| Administration | 10 |
| ADP | 10 |
| NADPH | 10 |
| Q | 10 |
| NDP | 10 |
| Streptococcus | 10 |
| vitexin | 10 |
| sarcopenic | 10 |
| pH | 10 |
| cathelicidin | 10 |
| Women | 10 |
| Whitney | 10 |
| Th17 | 10 |
| Tasmania | 10 |
| TLRs | 10 |
| T2DM | 10 |
| T1DM | 10 |
| NTproBNP | 10 |
| Status | 10 |
| Regulation | 10 |
| Natural | 10 |
| Pandemic | 10 |
| Pathway | 10 |
| Prospective | 10 |
| Pregnancy | 10 |
| S3 | 10 |
| SCFA | 10 |
| Scientific | 10 |
| Sigma | 10 |
| Start | 10 |
| Induced | 9 |
| High | 9 |
| IL-1β | 9 |
| IV | 9 |
| IgG1 | 9 |
| Lipid | 9 |
| Ireland | 9 |
| Islander | 9 |
| IκBα | 9 |
| J5 | 9 |
| Lifestyle | 9 |
| 9 | |
| HBV | 9 |
| Czech | 9 |
| Foods | 9 |
| Ethics | 9 |
| Estonia | 9 |
| Declaration | 9 |
| Data | 9 |
| Centre | 9 |
| Bulgaria | 9 |
| Bio | 9 |
| Based | 9 |
| Antioxidant | 9 |
| Akt | 9 |
| M. | 9 |
| Aboriginal | 9 |
| Long | 9 |
| MO | 9 |
| School | 9 |
| Major | 9 |
| oleuropein | 9 |
| ng | 9 |
| mmol | 9 |
| hydroxytyrosol | 9 |
| Trials | 9 |
| Torres | 9 |
| TLR4 | 9 |
| Strait | 9 |
| Statistics | 9 |
| Staphylococcus | 9 |
| Self | 9 |
| System | 9 |
| S. | 9 |
| Plasma | 9 |
| Resistance | 9 |
| Mouse | 9 |
| Osteosarcopenia | 9 |
| PREDIMED | 9 |
| Placebo | 9 |
| May | 9 |
| Policy | 9 |
| Quality | 9 |
| REVIEW | 9 |
| Recommendations | 9 |
| Potential | 9 |
| Government | 8 |
| EGCG | 8 |
| East | 8 |
| Expert | 8 |
| Federation | 8 |
| Gestational | 8 |
| HbA1c | 8 |
| Growth | 8 |
| Hospital | 8 |
| I. | 8 |
| Inhibition | 8 |
| Drug | 8 |
| EBT | 8 |
| July | 8 |
| Delivery | 8 |
| December | 8 |
| Crohn | 8 |
| Cohort | 8 |
| Clinic | 8 |
| CD14 | 8 |
| BMD | 8 |
| Austria | 8 |
| Appendix | 8 |
| America | 8 |
| Action | 8 |
| Access | 8 |
| ATP | 8 |
| Insulin | 8 |
| Mass | 8 |
| Kruskal | 8 |
| Shutdown | 8 |
| Law | 8 |
| el | 8 |
| acid | 8 |
| Zinc | 8 |
| Weight | 8 |
| Wallis | 8 |
| Trends | 8 |
| Syndrome | 8 |
| Sweden | 8 |
| Support | 8 |
| St. | 8 |
| Sir2 | 8 |
| WHO | 8 |
| Safety | 8 |
| Milk | 8 |
| Properties | 8 |
| Louis | 8 |
| MAC | 8 |
| osteosarcopenic | 8 |
| Middle | 8 |
| Mice | 8 |
| NMRK | 8 |
| Periodontal | 8 |
| Plan | 8 |
| Polyphenols | 8 |
| Practice | 8 |
| Elderly | 7 |
| Fetal | 7 |
| Endocrine | 7 |
| FGR | 7 |
| Factors | 7 |
| Family | 7 |
| Federal | 7 |
| Immunity | 7 |
| Free | 7 |
| GI | 7 |
| GraphPad | 7 |
| Hungary | 7 |
| IBM | 7 |
| IRF7 | 7 |
| ESTHER | 7 |
| Early | 7 |
| Asian | 7 |
| Denmark | 7 |
| Board | 7 |
| AICAR | 7 |
| Activation | 7 |
| Intervention | 7 |
| Australians | 7 |
| Author | 7 |
| Biomarkers | 7 |
| CRC | 7 |
| DNA | 7 |
| CVR | 7 |
| Cells | 7 |
| Chicago | 7 |
| Children | 7 |
| Colorectal | 7 |
| Consumption | 7 |
| Innate | 7 |
| Expression | 7 |
| Interventions | 7 |
| SPSS | 7 |
| Sirt1 | 7 |
| Standards | 7 |
| Stata | 7 |
| TLR2 | 7 |
| Th2 | 7 |
| Tregs | 7 |
| U | 7 |
| Unit | 7 |
| Upper | 7 |
| Use | 7 |
| Working | 7 |
| enterotoxigenic | 7 |
| lactis | 7 |
| μmol | 7 |
| Latvia | 7 |
| SUN | 7 |
| WC | 7 |
| SES | 7 |
| Optimal | 7 |
| Mechanism | 7 |
| S5 | 7 |
| Microbiota | 7 |
| NCD | 7 |
| NOD2 | 7 |
| NRH | 7 |
| Mini | 7 |
| PARPs | 7 |
| Response | 7 |
| Pilot | 7 |
| Population | 7 |
| Palou | 7 |
| Project | 7 |
| H | 6 |
| IL-15 | 6 |
| IL | 6 |
| HFSSM | 6 |
| H9N2 | 6 |
| GEE | 6 |
| Grant | 6 |
| G.C. | 6 |
| Functional | 6 |
| Foundation | 6 |
| Immunonutrition | 6 |
| Fruit | 6 |
| IL-5 | 6 |
| Japan | 6 |
| Index | 6 |
| Infection | 6 |
| Injury | 6 |
| Institutional | 6 |
| Interferon | 6 |
| Kingdom | 6 |
| LCPUFA | 6 |
| Lacticaseibacillus | 6 |
| Lp(a | 6 |
| MA | 6 |
| Epidemiology | 6 |
| MERS | 6 |
| FMPI | 6 |
| Brain | 6 |
| English | 6 |
| Emergency | 6 |
| Mainland | 6 |
| A7 | 6 |
| A8 | 6 |
| ALI | 6 |
| APACHE | 6 |
| Act | 6 |
| Anti | 6 |
| Antimicrobial | 6 |
| Associated | 6 |
| Autophagy | 6 |
| Bcl-2 | 6 |
| Breast | 6 |
| CR | 6 |
| CSC | 6 |
| CT | 6 |
| Ca | 6 |
| Cellular | 6 |
| Commission | 6 |
| Crisis | 6 |
| Cross | 6 |
| Distress | 6 |
| E | 6 |
| ELISA | 6 |
| EPIC | 6 |
| ER | 6 |
| MMP-9 | 6 |
| Oral | 6 |
| Management | 6 |
| SD | 6 |
| SOD | 6 |
| Saarland | 6 |
| Science | 6 |
| Scly | 6 |
| Screening | 6 |
| Short | 6 |
| Spearman | 6 |
| Term | 6 |
| Third | 6 |
| Tissue | 6 |
| Type | 6 |
| Vegetable | 6 |
| WAT | 6 |
| control | 6 |
| defensin | 6 |
| docosahexaenoic | 6 |
| hyperimmune | 6 |
| hypovitaminosis | 6 |
| mediterranean | 6 |
| mononucleotide | 6 |
| nicotinamide | 6 |
| sirtuin | 6 |
| thermophilus | 6 |
| Mental | 6 |
| ≤ | 6 |
| SELENOF | 6 |
| browning | 6 |
| SAS | 6 |
| PPD | 6 |
| Metabolic | 6 |
| Micronutrient | 6 |
| S7 | 6 |
| Mitochondrial | 6 |
| Module | 6 |
| Mucosal | 6 |
| NADP | 6 |
| Netherlands | 6 |
| Northern | 6 |
| Norway | 6 |
| Nutr | 6 |
| NMRK2 | 6 |
| Patient | 6 |
| Q3 | 6 |
| Romania | 6 |
| Related | 6 |
| Receptor | 6 |
| S2 | 6 |
| Rad | 6 |
| Q1 | 6 |
| Province | 6 |
| Portugal | 6 |
| People | 6 |
| S6 | 6 |
| Fatigue | 5 |
| F | 5 |
| Extract | 5 |
| Economic | 5 |
| EU | 5 |
| District | 5 |
| D. | 5 |
| Dengue | 5 |
| DMSO | 5 |
| DENV-2 | 5 |
| Complications | 5 |
| Cyprus | 5 |
| Curcuma | 5 |
| Function | 5 |
| County | 5 |
| Francisco | 5 |
| Indians | 5 |
| G7 | 5 |
| Ill | 5 |
| College | 5 |
| Joint | 5 |
| JobSeeker | 5 |
| JobKeeper | 5 |
| Intakes | 5 |
| Induction | 5 |
| IR | 5 |
| GALT | 5 |
| IL-18 | 5 |
| Host | 5 |
| Hepatitis | 5 |
| Greece | 5 |
| General | 5 |
| Gene | 5 |
| Colostrum | 5 |
| Acute | 5 |
| City | 5 |
| ARI | 5 |
| ApoB | 5 |
| ApoA | 5 |
| Apo | 5 |
| Aldrich | 5 |
| Agency | 5 |
| Affairs | 5 |
| AOR | 5 |
| BPA | 5 |
| ANOVA | 5 |
| AMP | 5 |
| A1 | 5 |
| A. | 5 |
| 8) | 5 |
| Kitchen | 5 |
| BAT | 5 |
| Behavior | 5 |
| Cidea | 5 |
| CCL5 | 5 |
| Cell | 5 |
| Cardiac | 5 |
| CSF | 5 |
| COX-2 | 5 |
| COVIDiet | 5 |
| CCM | 5 |
| British | 5 |
| Belgium | 5 |
| Breakfast | 5 |
| Bonferroni | 5 |
| Bone | 5 |
| Body | 5 |
| Binding | 5 |
| Berlin | 5 |
| K.K. | 5 |
| VPA | 5 |
| Korea | 5 |
| Stress | 5 |
| UCP1 | 5 |
| Transport | 5 |
| Total | 5 |
| TLR7 | 5 |
| TGF | 5 |
| Systems | 5 |
| Statistical | 5 |
| Victoria | 5 |
| Srebp-1c | 5 |
| Socio | 5 |
| Singapore | 5 |
| Signaling | 5 |
| Services | 5 |
| Service | 5 |
| Version | 5 |
| Vitamin | 5 |
| Scutellaria | 5 |
| kB | 5 |
| LP | 5 |
| ≥ | 5 |
| −80 | 5 |
| resolvins | 5 |
| parainfluenza | 5 |
| kappaB | 5 |
| hepatitis | 5 |
| Vivo | 5 |
| gasseri | 5 |
| alba | 5 |
| Zealand | 5 |
| Wnt | 5 |
| Westmead | 5 |
| Wang | 5 |
| September | 5 |
| diet | 5 |
| Screener | 5 |
| NY | 5 |
| Panel | 5 |
| PAE | 5 |
| Opinion | 5 |
| ONS | 5 |
| Nrf2 | 5 |
| Niacin | 5 |
| NS5B | 5 |
| Pearson | 5 |
| NJ | 5 |
| Molecular | 5 |
| Meal | 5 |
| Maternal | 5 |
| SIRT6 | 5 |
| MAPT | 5 |
| Participation | 5 |
| Mortality | 5 |
| Peyer | 5 |
| Radic | 5 |
| S.M. | 5 |
| Placental | 5 |
| SE | 5 |
| S.C. | 5 |
| Role | 5 |
| RdRp | 5 |
| Russia | 5 |
| R. | 5 |
| Pneumonia | 5 |
| Pulmonary | 5 |
| Propionibacterium | 5 |
| Q10 | 5 |
| PubMed | 5 |
| IRF1 | 4 |
| Hunger | 4 |
| Hypertension | 4 |
| IGF-1 | 4 |
| IRF3 | 4 |
| ISG15 | 4 |
| IgE | 4 |
| Guideline | 4 |
| Immunoglobulin | 4 |
| Illness | 4 |
| Healthcare | 4 |
| French | 4 |
| Guide | 4 |
| Granada | 4 |
| GmbH | 4 |
| Georgia | 4 |
| GPx3 | 4 |
| Fortification | 4 |
| Form | 4 |
| Flavonoid | 4 |
| Fisher | 4 |
| First | 4 |
| Inflammatory | 4 |
| Fab | 4 |
| Indonesia | 4 |
| Luxembourg | 4 |
| Intensive | 4 |
| Interactions | 4 |
| Enteral | 4 |
| Men | 4 |
| Measuring | 4 |
| McCall | 4 |
| Malays | 4 |
| MM-2 | 4 |
| MDA5 | 4 |
| MDA | 4 |
| M1 | 4 |
| López | 4 |
| Lung | 4 |
| Lunch | 4 |
| Lockdown | 4 |
| Likert | 4 |
| Levels | 4 |
| Lee | 4 |
| LDL-4 | 4 |
| Java | 4 |
| J.P. | 4 |
| Iran | 4 |
| Investigation | 4 |
| Inverse | 4 |
| Inventory | 4 |
| FGF2 | 4 |
| Biological | 4 |
| England | 4 |
| Emerging | 4 |
| Bureau | 4 |
| Brown | 4 |
| Blood | 4 |
| Bl-04 | 4 |
| Biosynthesis | 4 |
| Behavioral | 4 |
| Beck | 4 |
| Baicalin | 4 |
| Australian | 4 |
| August | 4 |
| Apoptosis | 4 |
| Ameliorates | 4 |
| Alliance | 4 |
| Alcohol | 4 |
| Age | 4 |
| Adipose | 4 |
| ACE2 | 4 |
| A6 | 4 |
| A11 | 4 |
| A.Z. | 4 |
| A.G. | 4 |
| A.E. | 4 |
| Metabolism | 4 |
| Butyrate | 4 |
| CAP | 4 |
| CNLC | 4 |
| Countries | 4 |
| Effectiveness | 4 |
| EPS | 4 |
| Docosahexaenoic | 4 |
| Disorders | 4 |
| Diego | 4 |
| Diagnostic | 4 |
| Diagnosis | 4 |
| Deaths | 4 |
| Croatia | 4 |
| Critically | 4 |
| Consultation | 4 |
| CREB | 4 |
| Confinement | 4 |
| Concentrations | 4 |
| Chromatography | 4 |
| Childhood | 4 |
| Centers | 4 |
| Census | 4 |
| Catholic | 4 |
| Case | 4 |
| Calcitriol | 4 |
| CXCL8 | 4 |
| Mercury | 4 |
| Karelia | 4 |
| Multicenter | 4 |
| aOR | 4 |
| ZO-1 | 4 |
| Young | 4 |
| White | 4 |
| Wenjuan | 4 |
| WI | 4 |
| WCRF | 4 |
| Validation | 4 |
| VEGF | 4 |
| Union | 4 |
| Ultra | 4 |
| Uganda | 4 |
| URI | 4 |
| UPLC | 4 |
| UA | 4 |
| Trp | 4 |
| Treg | 4 |
| Therapeutic | 4 |
| Theory | 4 |
| Target | 4 |
| TAFE | 4 |
| Symptom | 4 |
| Summit | 4 |
| Summary | 4 |
| Zhang | 4 |
| adipocytes | 4 |
| Slovakia | 4 |
| association | 4 |
| Muscle | 4 |
| wogonin | 4 |
| sarcopenia | 4 |
| protectins | 4 |
| paracasei | 4 |
| naringenin | 4 |
| myricetin-3-rhamnoside | 4 |
| maresins | 4 |
| luteolin | 4 |
| lipoteichoic | 4 |
| kazinoki | 4 |
| kaempferol | 4 |
| isorhamnetin | 4 |
| interleukin-6 | 4 |
| h. | 4 |
| enterocytes | 4 |
| der | 4 |
| colostrum | 4 |
| cholecalciferol | 4 |
| ceruloplasmin | 4 |
| brown | 4 |
| biosynthesis | 4 |
| bacterin | 4 |
| Slovenia | 4 |
| novo | 4 |
| Single | 4 |
| Perspective | 4 |
| Pectolinarin | 4 |
| Pb | 4 |
| Pattern | 4 |
| Pathways | 4 |
| Pathogenesis | 4 |
| 4 | |
| Pac | 4 |
| PTB | 4 |
| PRR | 4 |
| PHQ-4 | 4 |
| PARP | 4 |
| PA | 4 |
| P.P. | 4 |
| Overview | 4 |
| Outbreak | 4 |
| Oseltamivir | 4 |
| OptiPrep | 4 |
| Nutrient | 4 |
| Nutricia | 4 |
| Nampt | 4 |
| NTCP | 4 |
| NAFLD | 4 |
| Sectional | 4 |
| Periodontic | 4 |
| News | 4 |
| Post | 4 |
| RIG | 4 |
| Saudi | 4 |
| Postbiotic | 4 |
| SBT2055 | 4 |
| SARM1 | 4 |
| S8 | 4 |
| S.E.M. | 4 |
| Rural | 4 |
| Resources | 4 |
| RT | 4 |
| RR | 4 |
| SIRT2 | 4 |
| REC | 4 |
| Prism | 4 |
| Postbiotics | 4 |
| Prevalence | 4 |
| RCT | 4 |
| Preventive | 4 |
| Sciences | 4 |
| Protective | 4 |
| Profile | 4 |
| Quarantine | 4 |
| Programs | 4 |
| Products | 4 |
| Hippocampal | 3 |
| Fund | 3 |
| Further | 3 |
| GCF | 3 |
| GCP | 3 |
| GD | 3 |
| GPX3 | 3 |
| GTT | 3 |
| Gaithersburg | 3 |
| García | 3 |
| Glycemic | 3 |
| Gilson | 3 |
| Glycyrrhizin | 3 |
| Guidance | 3 |
| Guinea | 3 |
| HR | 3 |
| HSV-1 | 3 |
| Heart | 3 |
| Hepatic | 3 |
| Hernández | 3 |
| Fried | 3 |
| Herpes | 3 |
| HPLC | 3 |
| F. | 3 |
| Fisheries | 3 |
| Erythrina | 3 |
| EUROSTAT | 3 |
| Homeostasis | 3 |
| EVOO | 3 |
| Eduardo | 3 |
| Electronic | 3 |
| Empowerment | 3 |
| Enhanced | 3 |
| Enterovirus | 3 |
| Entry | 3 |
| Ethiopia | 3 |
| Fight | 3 |
| Evidence | 3 |
| Extension | 3 |
| FCGRT | 3 |
| FPL | 3 |
| Fabaceae | 3 |
| 3 | |
| Families | 3 |
| Fasn | 3 |
| Fat | 3 |
| Home | 3 |
| Kashin | 3 |
| House | 3 |
| Hypovitaminosis | 3 |
| Keshan | 3 |
| Kinase | 3 |
| Knowledge | 3 |
| Kolmogorov | 3 |
| Laboratories | 3 |
| Lactobacilli | 3 |
| Level | 3 |
| Li | 3 |
| Liquid | 3 |
| Longa | 3 |
| Loss | 3 |
| M | 3 |
| M.R. | 3 |
| M.T. | 3 |
| M2 | 3 |
| MCA | 3 |
| MS | 3 |
| Maoto | 3 |
| Map | 3 |
| Mateo | 3 |
| EPSs | 3 |
| Kefiran | 3 |
| KO | 3 |
| Jun | 3 |
| Independent | 3 |
| IBD | 3 |
| IKK | 3 |
| IPD | 3 |
| Identification | 3 |
| Illinois | 3 |
| Immunomodulatory | 3 |
| Implementation | 3 |
| Incidence | 3 |
| Increased | 3 |
| Indexes | 3 |
| J. | 3 |
| Infant | 3 |
| Inflammation | 3 |
| Information | 3 |
| Innsbruck | 3 |
| Insight | 3 |
| Interaction | 3 |
| Interleukin-6 | 3 |
| Interview | 3 |
| Invitrogen | 3 |
| ES | 3 |
| CHB | 3 |
| EDA | 3 |
| CXCL9 | 3 |
| Attenuates | 3 |
| Authority | 3 |
| Axis | 3 |
| B12 | 3 |
| BRSV | 3 |
| Bacillus | 3 |
| Barrier | 3 |
| Basic | 3 |
| Bax | 3 |
| Behaviour | 3 |
| Behaviours | 3 |
| Biobank | 3 |
| Birth | 3 |
| Black | 3 |
| Blind | 3 |
| C.S. | 3 |
| C57BL/6J | 3 |
| CCL27 | 3 |
| CD80 | 3 |
| MeOH | 3 |
| COVID | 3 |
| Arterial | 3 |
| Armonk | 3 |
| Arg-1 | 3 |
| Acc-1 | 3 |
| 3T3L1 | 3 |
| A2 | 3 |
| A71 | 3 |
| ADL | 3 |
| ADPR | 3 |
| AG | 3 |
| AIDS | 3 |
| ASM | 3 |
| Abdulaziz | 3 |
| Activities | 3 |
| Arabia | 3 |
| Acyl | 3 |
| Adaptive | 3 |
| Advisors | 3 |
| African | 3 |
| Against | 3 |
| Agrp | 3 |
| Antidepressant | 3 |
| Application | 3 |
| Approach | 3 |
| COVID19 | 3 |
| Caffeic | 3 |
| ECLB | 3 |
| Campylobacter | 3 |
| Contribution | 3 |
| Cooking | 3 |
| Cooperative | 3 |
| Corp. | 3 |
| Cyclotides | 3 |
| D.C. | 3 |
| DCM | 3 |
| DMD | 3 |
| DMEM | 3 |
| Dairy | 3 |
| Database | 3 |
| David | 3 |
| De | 3 |
| Death | 3 |
| Developmental | 3 |
| Disorder | 3 |
| Disticella | 3 |
| Distribution | 3 |
| Donkey | 3 |
| Dose | 3 |
| E.L. | 3 |
| Consensus | 3 |
| Comprehensive | 3 |
| Complex | 3 |
| ClinicalTrials.gov | 3 |
| Capacity | 3 |
| Cary | 3 |
| Cationic | 3 |
| Celecoxib | 3 |
| Celia | 3 |
| Chain | 3 |
| Characteristics | 3 |
| Chen | 3 |
| Chloride | 3 |
| Co | 3 |
| Complementary | 3 |
| CoA | 3 |
| Cochrane | 3 |
| Cocinar | 3 |
| Cognitive | 3 |
| Cohen | 3 |
| Cold | 3 |
| Colonic | 3 |
| Columbia | 3 |
| Common | 3 |
| Materials | 3 |
| Allotments | 3 |
| Measurement | 3 |
| Structural | 3 |
| Subsequent | 3 |
| Sugar | 3 |
| Suihua | 3 |
| Sun | 3 |
| Synbiotics | 3 |
| Systemic | 3 |
| TG | 3 |
| TM | 3 |
| Territory | 3 |
| Test | 3 |
| Th | 3 |
| Th-1 | 3 |
| Th-2 | 3 |
| Th1 | 3 |
| Th1-type | 3 |
| Th2-mediated | 3 |
| Time | 3 |
| Tolerable | 3 |
| Toronto | 3 |
| Transtheoretical | 3 |
| Tuolumne | 3 |
| Structure | 3 |
| Strategies | 3 |
| S4 | 3 |
| Station | 3 |
| SC | 3 |
| SIRT3 | 3 |
| SMDDS | 3 |
| SNPs | 3 |
| SU.VI.MAX | 3 |
| SVCT1 | 3 |
| SVneo | 3 |
| Salivary | 3 |
| Salud | 3 |
| Schleicher | 3 |
| Scienza | 3 |
| Scotch | 3 |
| Seasonal | 3 |
| Sebia | 3 |
| Secondary | 3 |
| Severe | 3 |
| Shapiro | 3 |
| Shenzhen | 3 |
| Smirnov | 3 |
| Spectrometry | 3 |
| StataCorp | 3 |
| TurkPrime | 3 |
| V.K. | 3 |
| Vitexin | 3 |
| Vitro | 3 |
| fed | 3 |
| freudenreichii | 3 |
| herpes | 3 |
| intestinalis | 3 |
| kefiran | 3 |
| lipoprotein | 3 |
| longum | 3 |
| metabolome | 3 |
| metapneumovirus | 3 |
| national | 3 |
| osteoporotic | 3 |
| phospho | 3 |
| poly | 3 |
| services | 3 |
| social | 3 |
| synbiotics | 3 |
| urolithin | 3 |
| µM | 3 |
| µg | 3 |
| µg/100 | 3 |
| Melissa | 3 |
| equol | 3 |
| dysenteriae | 3 |
| diarrheagenic | 3 |
| acyl | 3 |
| Vorland | 3 |
| WCOH | 3 |
| Waters | 3 |
| Wilk | 3 |
| Yakut | 3 |
| Yakutia | 3 |
| Ym-1 | 3 |
| Zaragoza | 3 |
| Zika | 3 |
| analysis | 3 |
| della | 3 |
| breve | 3 |
| brite | 3 |
| calcitriol | 3 |
| casei | 3 |
| caspase-3 | 3 |
| catechin | 3 |
| chi | 3 |
| chylomicron | 3 |
| cm | 3 |
| S9 | 3 |
| YMC | 3 |
| S11 | 3 |
| Personal | 3 |
| Nymphaea | 3 |
| OH | 3 |
| OM-85 | 3 |
| October | 3 |
| Oil | 3 |
| Olive | 3 |
| OmegAD | 3 |
| Open | 3 |
| Organic | 3 |
| Overweight | 3 |
| PEER | 3 |
| PI3 | 3 |
| PRISMA | 3 |
| Pack | 3 |
| Palliative | 3 |
| Para | 3 |
| Parenteral | 3 |
| Parkinson | 3 |
| Pathophysiological | 3 |
| Pellegrini | 3 |
| Performance | 3 |
| Nut | 3 |
| Norfolk | 3 |
| Nmrk1 | 3 |
| Mrc-1 | 3 |
| Mellitus | 3 |
| S10 | 3 |
| Method | 3 |
| Mgl | 3 |
| Microbiome | 3 |
| Middleton | 3 |
| Mitophagy | 3 |
| Monocyte | 3 |
| Moringa | 3 |
| Multidomain | 3 |
| Nations | 3 |
| Murcia | 3 |
| Mycobacterium | 3 |
| N | 3 |
| N.L. | 3 |
| NADH | 3 |
| NC | 3 |
| NIH | 3 |
| NLRP3 | 3 |
| Naringenin | 3 |
| Periodontology | 3 |
| Neutrophil | 3 |
| Perspectives | 3 |
| Qualitative | 3 |
| Questionnaire | 3 |
| RBC | 3 |
| REDCap | 3 |
| RRV | 3 |
| Randomised | 3 |
| Rat | 3 |
| Rationale | 3 |
| Rats | 3 |
| Recognition | 3 |
| Registry | 3 |
| Regulatory | 3 |
| Renilla | 3 |
| Renzo | 3 |
| Requirements | 3 |
| Riyadh | 3 |
| Rodnan | 3 |
| Rodríguez | 3 |
| Russian | 3 |
| Phenotype | 3 |
| Ruíz | 3 |
| S | 3 |
| Quantitative | 3 |
| Red | 3 |
| Pérez | 3 |
| Predictors | 3 |
| Phytochemicals | 3 |
| Phytochemical | 3 |
| Placenta | 3 |
| Publishing | 3 |
| Plains | 3 |
| Plant | 3 |
| Plate | 3 |
| Polyphenol | 3 |
| Poverty | 3 |
| Precursor | 3 |
| Plex | 3 |
| Preiss | 3 |
| Price | 3 |
| Primary | 3 |
| Pro | 3 |
| Probiotic | 3 |
| Preeclampsia | 3 |
| Probiotics | 3 |
| Programming | 3 |
| Problem | 3 |
| HLA | 2 |
| HBoV | 2 |
| HALE | 2 |
| HOMA | 2 |
| HAV | 2 |
| HFD)-fed | 2 |
| HED | 2 |
| HEK293 | 2 |
| HG | 2 |
| HILIC | 2 |
| H. | 2 |
| H2O2 | 2 |
| Geographic | 2 |
| Gyrus | 2 |
| Guerra | 2 |
| Groups | 2 |
| Greater | 2 |
| Grade | 2 |
| Glycemia | 2 |
| Glasgow | 2 |
| German | 2 |
| Genotypes | 2 |
| Genomic | 2 |
| Genes | 2 |
| HPA | 2 |
| Genetic | 2 |
| HOXC9 | 2 |
| Honey | 2 |
| HRMS | 2 |
| HSV | 2 |
| Huh-7 | 2 |
| Gap | 2 |
| Hughes | 2 |
| Hu | 2 |
| Hs | 2 |
| Hong | 2 |
| Hochberg | 2 |
| Histone | 2 |
| Histological | 2 |
| Hill | 2 |
| HgbA1c | 2 |
| Heparin | 2 |
| HepG2 | 2 |
| Hela | 2 |
| Heavy | 2 |
| Heat | 2 |
| Hawaii | 2 |
| Hasan | 2 |
| Harmony | 2 |
| Haplotypes | 2 |
| Handler | 2 |
| Han | 2 |
| Hamburg | 2 |
| HTR8 | 2 |
| HSV-2 | 2 |
| Gender | 2 |
| Epigenetics | 2 |
| GU | 2 |
| Fas | 2 |
| Factor | 2 |
| FO | 2 |
| FFA | 2 |
| FBS | 2 |
| FAO | 2 |
| F.C. | 2 |
| Extra | 2 |
| Experimental | 2 |
| Experiential | 2 |
| Expenditures | 2 |
| Exopolysaccharides | 2 |
| Europeans | 2 |
| Esther | 2 |
| Essential | 2 |
| Esparza | 2 |
| Enhancement | 2 |
| Engagement | 2 |
| Energy | 2 |
| Elsa | 2 |
| El | 2 |
| Eicosanoids | 2 |
| Eggersdorfer | 2 |
| Ecological | 2 |
| Eclipta | 2 |
| Hydroxytyrosol | 2 |
| Failure | 2 |
| FcRB | 2 |
| GSK-3β | 2 |
| Feasibility | 2 |
| GPower | 2 |
| GPX1 | 2 |
| GM | 2 |
| GLP-1 | 2 |
| GH | 2 |
| GE | 2 |
| Future | 2 |
| Froot | 2 |
| Front | 2 |
| Friedy | 2 |
| Frenchay | 2 |
| Framingham | 2 |
| Fracture | 2 |
| FoxP3 | 2 |
| Formulations | 2 |
| Forms | 2 |
| Force | 2 |
| FokI | 2 |
| Fluid | 2 |
| Flos | 2 |
| Fleischner | 2 |
| Flavonols | 2 |
| Finnish | 2 |
| File | 2 |
| Fibrosis | 2 |
| Hydrocarbon | 2 |
| Lipoteichoic | 2 |
| Hypericum | 2 |
| Lancet | 2 |
| Lam | 2 |
| Ladanein | 2 |
| Lactiplantibacillus | 2 |
| La | 2 |
| LRTI | 2 |
| LGA | 2 |
| LDL-5 | 2 |
| LC705 | 2 |
| LA | 2 |
| L74 | 2 |
| L.B. | 2 |
| Kong | 2 |
| King | 2 |
| Kids | 2 |
| Kenya | 2 |
| Kcal | 2 |
| Kasckovics | 2 |
| Kaposi | 2 |
| Kapoor | 2 |
| Kaplan | 2 |
| Kaiser | 2 |
| Ka | 2 |
| KSHV | 2 |
| KRIBB | 2 |
| KB290 | 2 |
| Lamiaceae | 2 |
| Langerhans | 2 |
| K. | 2 |
| Latinx | 2 |
| MCP-1 | 2 |
| MCC1849 | 2 |
| MAVS | 2 |
| M.P. | 2 |
| Lymphoid | 2 |
| Luteolin | 2 |
| Luis | 2 |
| Lucky | 2 |
| Ltd. | 2 |
| Loops | 2 |
| Longitudinal | 2 |
| Lodz | 2 |
| Local | 2 |
| Liver | 2 |
| Liu | 2 |
| Lithuanians | 2 |
| Lisses | 2 |
| Ebola | 2 |
| Lim | 2 |
| Like | 2 |
| Liberia | 2 |
| Lewkowicz | 2 |
| Levilactobacillus | 2 |
| League | 2 |
| Layer | 2 |
| KACST | 2 |
| Julia | 2 |
| Hypothesis | 2 |
| Indicator | 2 |
| Implications | 2 |
| Impacts | 2 |
| Immunobiotic | 2 |
| Immunization | 2 |
| Il-6 | 2 |
| IgM. | 2 |
| Ig | 2 |
| IUGR | 2 |
| ISGs | 2 |
| IPS-1 | 2 |
| IOM | 2 |
| INTEC | 2 |
| IL-29 | 2 |
| IL-23 | 2 |
| IL-21 | 2 |
| IL-12p40 | 2 |
| IL-1-induced | 2 |
| IGF | 2 |
| IFD | 2 |
| IDS | 2 |
| ID | 2 |
| ICH | 2 |
| ICAM)-1 | 2 |
| I-1518 | 2 |
| I)-like | 2 |
| Improved | 2 |
| Inequality | 2 |
| Johnson | 2 |
| Infectious | 2 |
| Jesús | 2 |
| Jessica | 2 |
| Jang | 2 |
| Jan | 2 |
| JNK | 2 |
| JG | 2 |
| JEOL | 2 |
| JAK2 | 2 |
| JAK | 2 |
| Italians | 2 |
| Issues | 2 |
| Issue | 2 |
| Issuance | 2 |
| Island | 2 |
| Iron | 2 |
| Invasion | 2 |
| Intracellular | 2 |
| Intra | 2 |
| Intestinal | 2 |
| Interpretation | 2 |
| Internal | 2 |
| Interleukin-1 | 2 |
| Inter | 2 |
| Integrative | 2 |
| Innovation | 2 |
| Echinacea | 2 |
| Cardiology | 2 |
| Eating | 2 |
| Biochem | 2 |
| Bignoniaceae | 2 |
| Bifidobacterium | 2 |
| Bifidobacteria | 2 |
| Beyond | 2 |
| Beverages | 2 |
| Betalains | 2 |
| Benjamini | 2 |
| Benefits | 2 |
| Benefit | 2 |
| Belén | 2 |
| Bayer | 2 |
| Bates | 2 |
| Barthel | 2 |
| Bank | 2 |
| Baltimore | 2 |
| Balance | 2 |
| Bachelor | 2 |
| BSA | 2 |
| BL | 2 |
| BDNF | 2 |
| BB | 2 |
| BALB | 2 |
| B.P. | 2 |
| Axonal | 2 |
| Atlas | 2 |
| Bioactive | 2 |
| Biocon | 2 |
| Aryl | 2 |
| Biomarker | 2 |
| CD157 | 2 |
| CD | 2 |
| CCL3 | 2 |
| CCL26 | 2 |
| CCL22 | 2 |
| CCL21 | 2 |
| CCL20 | 2 |
| CCL | 2 |
| CCID50 | 2 |
| CBA | 2 |
| C57BL/6 | 2 |
| C15H10O7 | 2 |
| Business | 2 |
| Buffer | 2 |
| Brussels | 2 |
| Broussoflavonol | 2 |
| Broiler | 2 |
| Brazil | 2 |
| Brambell | 2 |
| Bowel | 2 |
| Bo | 2 |
| Bisphenol | 2 |
| Biotechnology | 2 |
| Bioscience | 2 |
| Biomedical | 2 |
| Asians | 2 |
| Artacho | 2 |
| EULAR | 2 |
| Activated | 2 |
| Academy | 2 |
| AUC | 2 |
| ATCC | 2 |
| AQ | 2 |
| APC | 2 |
| AP-1 | 2 |
| AMPKα1 | 2 |
| ALT | 2 |
| ADLs | 2 |
| ACTRN | 2 |
| ACS | 2 |
| ABS | 2 |
| AAA | 2 |
| A9 | 2 |
| A549 | 2 |
| A3 | 2 |
| A10 | 2 |
| A.F. | 2 |
| 6E | 2 |
| 3.0 | 2 |
| 2F | 2 |
| 2D | 2 |
| -dependent | 2 |
| -8 | 2 |
| MMSE | 2 |
| Acsl | 2 |
| Added | 2 |
| Areas | 2 |
| Adequacy | 2 |
| Aragon | 2 |
| Anxiety | 2 |
| Antioxidants | 2 |
| Antibiotic | 2 |
| Antenatal | 2 |
| Anna | 2 |
| Anitra | 2 |
| Andrea | 2 |
| Anabrasky | 2 |
| Altern | 2 |
| Alteration | 2 |
| Allium | 2 |
| Alexander | 2 |
| Alaska | 2 |
| Al | 2 |
| AhR | 2 |
| Agouti | 2 |
| Agents | 2 |
| Agent | 2 |
| Aged | 2 |
| Afghanistan | 2 |
| Adrian | 2 |
| Adjusted | 2 |
| Adiposity | 2 |
| Adipocytes | 2 |
| CD4-LTR | 2 |
| CD40 | 2 |
| CD6 | 2 |
| Determinants | 2 |
| Design | 2 |
| Depressive | 2 |
| Dentate | 2 |
| Dendritic | 2 |
| Degeneration | 2 |
| Definition | 2 |
| Deficiency | 2 |
| Dectin-1 | 2 |
| Dark | 2 |
| DU1 | 2 |
| DSM-5 | 2 |
| DIMERICA | 2 |
| DA | 2 |
| D2 | 2 |
| Cytokines | 2 |
| Curcuminoids | 2 |
| Crystal | 2 |
| Critical | 2 |
| Coxsackie | 2 |
| Cox | 2 |
| CovILD | 2 |
| Cov-2 | 2 |
| Course | 2 |
| Council | 2 |
| Cortex | 2 |
| Detection | 2 |
| Determination | 2 |
| CD73 | 2 |
| DiSA | 2 |
| ESC | 2 |
| ERS | 2 |
| EFSA | 2 |
| EFAD | 2 |
| EC50 | 2 |
| Dyslipidemia | 2 |
| Dunnett | 2 |
| Dufsseldorf | 2 |
| Duchenne | 2 |
| Dr. | 2 |
| Downregulation | 2 |
| Double | 2 |
| Doses | 2 |
| Domain | 2 |
| Dolores | 2 |
| Docking | 2 |
| Do | 2 |
| Division | 2 |
| Digital | 2 |
| Differential | 2 |
| Dietitians | 2 |
| Diasorin | 2 |
| Diarrhea | 2 |
| Diabetic | 2 |
| Diabete | 2 |
| Corporation | 2 |
| Coronavirus-19 | 2 |
| Corona | 2 |
| Copper | 2 |
| Changsha | 2 |
| Challenges | 2 |
| Chachi | 2 |
| Cereals | 2 |
| Central | 2 |
| Celiac | 2 |
| Carr | 2 |
| Carlo | 2 |
| Carbohydrate | 2 |
| Canadian | 2 |
| Cambodia | 2 |
| Calder | 2 |
| CaCo-2 | 2 |
| CXCL16 | 2 |
| CXC | 2 |
| CV | 2 |
| CTLA-4 | 2 |
| CRL431 | 2 |
| CRA | 2 |
| COVID-19-Time | 2 |
| COVI-19 | 2 |
| CMMSE | 2 |
| CLNC | 2 |
| CEIH/2020 | 2 |
| CD86 | 2 |
| Charms | 2 |
| Cheerios | 2 |
| Chemical | 2 |
| Coenzyme | 2 |
| Content | 2 |
| Connecticut | 2 |
| Concern | 2 |
| Conceptualization | 2 |
| Conceptual | 2 |
| Compounds | 2 |
| Compound | 2 |
| Comparison | 2 |
| Commensal | 2 |
| Collaborators | 2 |
| Coffee | 2 |
| Cockayne | 2 |
| Chemokine | 2 |
| Coast | 2 |
| CoVID-19 | 2 |
| Co. | 2 |
| Clearance | 2 |
| Città | 2 |
| Citrus | 2 |
| Cincinnati | 2 |
| Cholesterol | 2 |
| Choi | 2 |
| Chin | 2 |
| Chigago | 2 |
| MDD | 2 |
| Inactivation | 2 |
| MUFA)-rich | 2 |
| Validity | 2 |
| Wages | 2 |
| Vlcad | 2 |
| Vito | 2 |
| Virology | 2 |
| Villanova | 2 |
| Veronica | 2 |
| Verkhoyansky | 2 |
| Verardo | 2 |
| Velden | 2 |
| Variations | 2 |
| Van | 2 |
| Value | 2 |
| Vahl | 2 |
| Silver | 2 |
| Vaccine | 2 |
| VF | 2 |
| VDD | 2 |
| VCAM-1 | 2 |
| V2 | 2 |
| V.P. | 2 |
| V. | 2 |
| V | 2 |
| Urh1 | 2 |
| Urban | 2 |
| Universität | 2 |
| Universidad | 2 |
| Wagner | 2 |
| Wako | 2 |
| Wales | 2 |
| Walmart | 2 |
| airways | 2 |
| aglycone | 2 |
| agency | 2 |
| a3 | 2 |
| a2 | 2 |
| a1 | 2 |
| Zucker | 2 |
| Zhongyu | 2 |
| ZEISS | 2 |
| Youth | 2 |
| YouTube | 2 |
| York | 2 |
| Years | 2 |
| Yao | 2 |
| YMCA | 2 |
| Y | 2 |
| Workers | 2 |
| Work | 2 |
| Windows | 2 |
| Williams | 2 |
| Wilcoxon | 2 |
| 2 | |
| Western | 2 |
| Welfare | 2 |
| 2 | |
| Univariate | 2 |
| Underfeeding | 2 |
| UPRP | 2 |
| TXRF | 2 |
| TNBS | 2 |
| TLR9 | 2 |
| TLR8 | 2 |
| THP-1 | 2 |
| T.F. | 2 |
| Sánchez | 2 |
| Syst | 2 |
| Synthesis | 2 |
| Sydney | 2 |
| Survival | 2 |
| Surgical | 2 |
| Super | 2 |
| Su | 2 |
| Strength | 2 |
| Strains | 2 |
| Stefania | 2 |
| Spotlight | 2 |
| Special | 2 |
| Southern | 2 |
| Southeast | 2 |
| Solanum | 2 |
| Solanaceae | 2 |
| Sohemy | 2 |
| Slc12a8 | 2 |
| Sirtuins | 2 |
| TX | 2 |
| Tables | 2 |
| UMH | 2 |
| Tangeretin | 2 |
| UHT | 2 |
| U. | 2 |
| 2 | |
| Tween | 2 |
| Turin | 2 |
| Tumor | 2 |
| Tsilingiri | 2 |
| Trust | 2 |
| Trump | 2 |
| Trophoblast | 2 |
| Trollii | 2 |
| Tomography | 2 |
| Tips | 2 |
| Thrifty | 2 |
| Thomas | 2 |
| Thermo | 2 |
| Th1-mediated | 2 |
| Tfh | 2 |
| Tetrastigma | 2 |
| Testing | 2 |
| Tencent | 2 |
| Technology | 2 |
| Technical | 2 |
| Tech | 2 |
| Task | 2 |
| alendronate | 2 |
| antiapoptotic | 2 |
| aspartyl | 2 |
| range | 2 |
| quercetin-3-rhamnoside | 2 |
| quercetagetin | 2 |
| qPCR | 2 |
| puerarin | 2 |
| proBNP | 2 |
| previtamin | 2 |
| preadipocytes | 2 |
| polymerase-1 | 2 |
| polyI | 2 |
| plantarum | 2 |
| pinocembrin | 2 |
| pgroup | 2 |
| peptide | 2 |
| peach | 2 |
| para | 2 |
| panel | 2 |
| pRL | 2 |
| organization | 2 |
| nephelometry | 2 |
| myxovirus | 2 |
| myricetin-3-(6-rhamnosylgalactoside | 2 |
| mid | 2 |
| metformin | 2 |
| mdx | 2 |
| manufacturer´s | 2 |
| quinolinic | 2 |
| sIgM | 2 |
| mRNAs | 2 |
| selectin | 2 |
| -chain | 2 |
| Ma | 2 |
| ≥50 | 2 |
| ≥10 | 2 |
| ≤5 | 2 |
| ≤25 | 2 |
| ≈1.5 | 2 |
| −70 | 2 |
| −2.5 | 2 |
| ∆ | 2 |
| ε4 | 2 |
| βcatenin | 2 |
| β1 | 2 |
| weight | 2 |
| virus-2 | 2 |
| vasculopathy | 2 |
| turkey | 2 |
| transporter-1 | 2 |
| tolerogenic | 2 |
| thionicotinamide | 2 |
| subgingival | 2 |
| stearoyl | 2 |
| ss | 2 |
| sobrinus | 2 |
| simplex | 2 |
| malondialdehyde | 2 |
| mL. | 2 |
| aspergillosis | 2 |
| desaturase-1 | 2 |
| defensins | 2 |
| deacetylases | 2 |
| day | 2 |
| dL | 2 |
| cyclooxygenase-2 | 2 |
| covid-19 | 2 |
| coronavirus-2 | 2 |
| committee | 2 |
| colostral | 2 |
| coli | 2 |
| class-1 | 2 |
| chymotrypsin | 2 |
| chitinaselike | 2 |
| caveolae | 2 |
| cART | 2 |
| buffalo | 2 |
| broussonol | 2 |
| broussoflavonol | 2 |
| bronchopulmonary | 2 |
| boulardii | 2 |
| board | 2 |
| bisdemethoxycurcumin | 2 |
| beige | 2 |
| baicalensis | 2 |
| baicalein | 2 |
| delbrueckii | 2 |
| docosanoid | 2 |
| lipoprotein(a | 2 |
| ds | 2 |
| lifespan | 2 |
| lactogenesis | 2 |
| kB. | 2 |
| inflammasome | 2 |
| immunostimulatory | 2 |
| immunomodulatory | 2 |
| immune | 2 |
| i.p | 2 |
| i.a | 2 |
| http://www.ANZCTR.org.au/ACTRN12611000456954.aspx | 2 |
| hs | 2 |
| helveticus | 2 |
| health | 2 |
| ham | 2 |
| gingivalis | 2 |
| genera | 2 |
| formyl | 2 |
| flavone | 2 |
| fermentum | 2 |
| extraction | 2 |
| enterocyte | 2 |
| en | 2 |
| eicosanoid | 2 |
| ebselen | 2 |
| east | 2 |
| Simplex | 2 |
| preβ | 2 |
| Sidor | 2 |
| Online | 2 |
| Odds | 2 |
| Observational | 2 |
| Obispo | 2 |
| Oberkochen | 2 |
| OLL1073R-1 | 2 |
| OHD | 2 |
| ODS | 2 |
| O | 2 |
| NutriNet | 2 |
| Nurses | 2 |
| Nuclear | 2 |
| Nrk1 | 2 |
| Notice | 2 |
| Nos | 2 |
| Normal | 2 |
| Nieman | 2 |
| Nfr2 | 2 |
| Neurological | 2 |
| Neurodegenerative | 2 |
| Network | 2 |
| Navarra | 2 |
| Nanoparticles | 2 |
| NaMN | 2 |
| NTD | 2 |
| NT | 2 |
| Oleuropein | 2 |
| Opportunity | 2 |
| NS5A | 2 |
| Organ | 2 |
| Paradox | 2 |
| Paper | 2 |
| Paolu | 2 |
| Paolo | 2 |
| PUFA)-rich | 2 |
| POLA | 2 |
| PND28 | 2 |
| PLAE | 2 |
| PLA | 2 |
| PKC | 2 |
| PI | 2 |
| PDGF | 2 |
| PDA | 2 |
| PBEF | 2 |
| PB2 | 2 |
| PB1 | 2 |
| PARP1 | 2 |
| PAMP | 2 |
| PAF | 2 |
| P.416768 | 2 |
| P. | 2 |
| Oxide | 2 |
| Oxidative | 2 |
| Overall | 2 |
| Other | 2 |
| NSC | 2 |
| NS2 | 2 |
| Park | 2 |
| Mississippi | 2 |
| Milford | 2 |
| MicroRNAs | 2 |
| Mexico | 2 |
| Methods | 2 |
| Metabolome | 2 |
| Meier | 2 |
| Meals | 2 |
| Mcp-1 | 2 |
| McNemar | 2 |
| Maturitas | 2 |
| Maturation | 2 |
| Material | 2 |
| Master | 2 |
| María | 2 |
| Martí | 2 |
| Market | 2 |
| Marine | 2 |
| Maria | 2 |
| Maram | 2 |
| Manfred | 2 |
| Maintenance | 2 |
| Main | 2 |
| Macrodomain | 2 |
| Shigella | 2 |
| Magdalena | 2 |
| Millions | 2 |
| Mitochondria | 2 |
| NRK | 2 |
| Mixed | 2 |
| NP | 2 |
| NOD1 | 2 |
| NMR | 2 |
| NMNAT | 2 |
| NIAGEN | 2 |
| NFκB | 2 |
| NEFA | 2 |
| NCFM | 2 |
| NADase | 2 |
| NADS | 2 |
| N#1874 | 2 |
| MxA | 2 |
| Muscular | 2 |
| Multiple | 2 |
| Muhammad | 2 |
| Mosdol | 2 |
| Mood | 2 |
| Monthly | 2 |
| Montes | 2 |
| Mononucleotide | 2 |
| Mongolia | 2 |
| Molina | 2 |
| Molecule | 2 |
| Models | 2 |
| Modeling | 2 |
| Parameters | 2 |
| Meat | 2 |
| Parliament | 2 |
| SECA | 2 |
| SARC | 2 |
| S5-S7 | 2 |
| S12 | 2 |
| S.V. | 2 |
| S.P. | 2 |
| S.G. | 2 |
| S.E.M | 2 |
| S.A. | 2 |
| Rzymski | 2 |
| Ruminal | 2 |
| Rotavirus | 2 |
| Roseburia | 2 |
| Root | 2 |
| Roles | 2 |
| Rich | 2 |
| Ribosome | 2 |
| Rheumatology | 2 |
| Rheumatism | 2 |
| Reyes | 2 |
| Rev | 2 |
| Retardation | 2 |
| Restrictions | 2 |
| Restriction | 2 |
| Restoration | 2 |
| Restaurant | 2 |
| SCCM | 2 |
| SELENOS | 2 |
| Resolution | 2 |
| SFA)-rich | 2 |
| Selol | 2 |
| Passive | 2 |
| Shanghai | 2 |
| Selenoproteins | 2 |
| Seguimiento | 2 |
| Sclerosis | 2 |
| Schomburg | 2 |
| Scholar | 2 |
| Scd-1 | 2 |
| Scarmozzino | 2 |
| Scand | 2 |
| Scad | 2 |
| Sample | 2 |
| Sambucus | 2 |
| Salute | 2 |
| Salmonella | 2 |
| Sakhija | 2 |
| Saccharomyces | 2 |
| SYBR | 2 |
| STROBE | 2 |
| STAT3 | 2 |
| STAT-1 | 2 |
| SOC8 | 2 |
| SLC23A1 | 2 |
| SFAs | 2 |
| Resolvin | 2 |
| Scale | 2 |
| ResearchGate | 2 |
| Promega | 2 |
| Production | 2 |
| Prevent | 2 |
| Preterm | 2 |
| Prebiotics | 2 |
| Pre | 2 |
| Practices | 2 |
| Power | 2 |
| Postpartum | 2 |
| Postnatal | 2 |
| Position | 2 |
| Porphyromonas | 2 |
| Populations | 2 |
| Polish | 2 |
| Polar | 2 |
| Pol | 2 |
| Poir | 2 |
| Pizarra | 2 |
| Philip | 2 |
| Phase | 2 |
| Persica | 2 |
| Pathology | 2 |
| Requirement | 2 |
| Pediatric | 2 |
| Patterns | 2 |
| Pathophysiology | 2 |
| Profiles | 2 |
| Pigs | 2 |
| Prostate | 2 |
| Ratio | 2 |
| Ren | 2 |
| Proteins | 2 |
| Region | 2 |
| Reform | 2 |
| Reference | 2 |
| Regional | 2 |
| Reproduction | 2 |
| Reduction | 2 |
| Recurrent | 2 |
| Recovery | 2 |
| Real | 2 |
| RdDp | 2 |
| RefR | 2 |
| Racial | 2 |
| R.V. | 2 |
| Psychiatric | 2 |
| Psychosocial | 2 |
| RV-16 | 2 |
| QA | 2 |
| R | 2 |
| Relationship | 2 |
| RTE | 2 |
| RAW264.1 | 2 |
| RAW264.7 | 2 |
| Hemolysis | 1 |
| Hmox1 | 1 |
| Hispanics | 1 |
| Hip | 1 |
| Hills | 1 |
| Hemoglobin | 1 |
| Hilger | 1 |
| Hilden | 1 |
| Highlights | 1 |
| Hierarchical | 1 |
| HgCl | 1 |
| Henry | 1 |
| Hepatocytes | 1 |
| Herrings | 1 |
| Hermann | 1 |
| Herbs | 1 |
| Herbal | 1 |
| Herba | 1 |
| Heraus | 1 |
| Hepatotoxicity | 1 |
| Hercules | 1 |
| Hormones | 1 |
| Hodgkin | 1 |
| Hospitalized | 1 |
| Hydragel | 1 |
| Hydrasys | 1 |
| Hybrid | 1 |
| HurriView | 1 |
| Hematopoietic | 1 |
| Hurley | 1 |
| Huo | 1 |
| Hub | 1 |
| Houttuynia | 1 |
| Households | 1 |
| Hospitalization | 1 |
| Hoermann | 1 |
| Hosmer | 1 |
| Horton | 1 |
| Hongnan | 1 |
| Homocysteine | 1 |
| Homo | 1 |
| Homes | 1 |
| Hologic | 1 |
| Holleczek | 1 |
| Hojsak | 1 |
| Hoitinga | 1 |
| Hemisphere | 1 |
| Hamilton | 1 |
| Hematopoiesis | 1 |
| Halftime | 1 |
| Hafizah | 1 |
| Haemoglobin | 1 |
| Haematological | 1 |
| Hadi | 1 |
| Hackler | 1 |
| Habits | 1 |
| Habedank | 1 |
| HYDRASYS | 1 |
| HYDRAGEL | 1 |
| HTR8/ | 1 |
| HSP70 | 1 |
| HREC | 1 |
| HMT | 1 |
| HMGB1-RAGE | 1 |
| HMGB1 | 1 |
| HIES | 1 |
| HGT-1 | 1 |
| Hydrocoll | 1 |
| HEp-2 | 1 |
| HELLP | 1 |
| HEPES | 1 |
| Hajj | 1 |
| Hallmarks | 1 |
| Helper | 1 |
| Hamadan | 1 |
| Helicobacter | 1 |
| Heidelberg | 1 |
| Hefei | 1 |
| Hecht | 1 |
| Hearing | 1 |
| Healthspan | 1 |
| Healthier | 1 |
| Hazaa | 1 |
| Haven | 1 |
| Haul | 1 |
| Hastie | 1 |
| Harvard | 1 |
| Harjit | 1 |
| Harbin | 1 |
| Haptoglobin | 1 |
| Hans | 1 |
| Hani | 1 |
| Handling | 1 |
| Handbook | 1 |
| Hand | 1 |
| Hamster | 1 |
| Hydraulic | 1 |
| IRE1α | 1 |
| Hydrophilic | 1 |
| Immunohistological | 1 |
| Immunodeficiency | 1 |
| Immunochemical | 1 |
| ImageJ | 1 |
| Ilaria | 1 |
| Il-1β | 1 |
| Il | 1 |
| Ignacio | 1 |
| IgGs | 1 |
| IgGFc | 1 |
| IgG2 | 1 |
| IgG. | 1 |
| IgD | 1 |
| IgA+ | 1 |
| IUPAC | 1 |
| IU/100 | 1 |
| ISG)15 | 1 |
| IRS-1 | 1 |
| IRF | 1 |
| IRAK | 1 |
| IQR | 1 |
| IP-10 | 1 |
| Immunodiagnostic | 1 |
| Immunological | 1 |
| Hydroxyethyl)-Aniline | 1 |
| Immunologie | 1 |
| Individual | 1 |
| Indices | 1 |
| HDV | 1 |
| Indicators | 1 |
| Ind | 1 |
| Incremental | 1 |
| Increase | 1 |
| Incorporation | 1 |
| Inchima | 1 |
| Inadequacy | 1 |
| Inactivity | 1 |
| Improving | 1 |
| Implication | 1 |
| Implant | 1 |
| Immunosuppressant | 1 |
| Immunostimulatory | 1 |
| Immunostimulation | 1 |
| Immunosenescence | 1 |
| Immunoregulatory | 1 |
| Immunopathology | 1 |
| Immunomodulator | 1 |
| IP | 1 |
| INFγ | 1 |
| INE | 1 |
| IMPLEN | 1 |
| ICPMR | 1 |
| ICG | 1 |
| ICD-10 | 1 |
| ICC | 1 |
| ICAM-1 | 1 |
| IC50 | 1 |
| IBMX | 1 |
| IBMRC | 1 |
| IADL | 1 |
| I-002/587/2019 | 1 |
| Hüttenberger | 1 |